FDA Approves Mimrylo for Polycythemia Vera, Offering a New Treatment Approach
FDA Approves Mimrylo for Polycythemia Vera, Offering a New Treatment Approach curetoday.com
Regulatory Approvals
F.D.A. Approves New Covid Vaccines, and They Should Be Available Soon
F.D.A. Approves New Covid Vaccines, and They Should Be Available Soon The New York Times
FDA Approves Rusfertide for Polycythemia Vera
FDA Approves Rusfertide for Polycythemia Vera Medscape
Dr Mesa on the FDA Approval of Ropeginterferon Alfa-2b for Essential Thrombocythemia
Dr Mesa on the FDA Approval of Ropeginterferon Alfa-2b for Essential Thrombocythemia OncLive
Recon: FDA approves Protagonist and Takeda’s drug for rare blood cancer; Lilly to buy Merida for up to $2.88B
Recon: FDA approves Protagonist and Takeda’s drug for rare blood cancer; Lilly to buy Merida for up to $2.88B RAPS